LIMN
Liminatus Pharma
$2.90
−$0.03 (−0.86%)Oct 29, 2026
Key metrics
The numbers that frame LIMN today
- Market cap
- $3.89M
- ROIC
- 442.2%
- Div yield
- 0%
- Debt / equity
- 4.8
- 52wk Low
- $2.79
- 52wk High
- $141.50
Growth
Revenue and earnings trend for LIMN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LIMN
Is Liminatus Pharma a good buy?
No. Liminatus Pharma has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Liminatus Pharma is selling at a very high price.
What is the market capitalization of LIMN?
Liminatus Pharma's market capitalization is $3.89M.
What is the 52-week high for LIMN stock?
The 52-week high for Liminatus Pharma is $141.50. The current close of $2.90 is 98% below that high.
What is the 52-week low for LIMN stock?
The 52-week low for Liminatus Pharma is $2.79. The current close of $2.90 is 3.9% above that low.
Does LIMN stock pay dividends?
Liminatus Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LIMN?
Liminatus Pharma's Debt / Equity ratio is 4.8.